Literature DB >> 15890546

Characteristics of peripheral microembolization during iliac stenting: Doppler ultrasound monitoring.

T Kudo1, Y Inoue, H Nakamura, N Sugano, M Hirokawa, T Iwai.   

Abstract

OBJECTIVE: To evaluate the characteristics of distal microembolic signals (MES) during iliac stenting using Doppler ultrasound monitoring.
DESIGN: Prospective clinical study.
METHODS: A 2-MHz probe was used to monitor continuously at the ipsilateral tibioperoneal trunks during technically and hemodynamically successful iliac stenting in 10 patients without infrainguinal occlusive lesion. MESs at guide-wire, balloon, or stent crossing (phase 1), predilatation (phase 2), stent deployment (phase 3), postdilatation (phase 4), and contrast medium or heparinized saline injection (at injection) were analyzed. Differentiation of gaseous emboli from particulate emboli was achieved by calculation of the sample volume length.
RESULTS: No distal embolic complications were observed. Five hundred and forty-one MESs were detected. The MES incidence and intensity in phase 3 were significantly higher than those in phase 1, phase 2, and phase 4 (p<0.05). The MES intensity at injection was significantly higher than that in each of four phases (p<0.0001).
CONCLUSIONS: Both the MES incidence and intensity were highest at stent deployment. Further study is required of microembolism during endovascular procedures in the lower extremities.

Entities:  

Mesh:

Year:  2005        PMID: 15890546     DOI: 10.1016/j.ejvs.2005.04.004

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  1 in total

1.  The usefulness of Duplex Doppler ultrasound in the angiological and dermatological diagnosis of patients with blue toe syndrome.

Authors:  Katarzyna Pawlaczyk; Marcin Gabriel; Daria A Strzelecka-Węklar; Zbigniew Krasiński; Michal Stanisic; Zofia Gabriel; Łukasz Dzieciuchowicz; Zygmunt Adamski
Journal:  Postepy Dermatol Alergol       Date:  2017-10-31       Impact factor: 1.837

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.